HERCULES, Calif. - Bio-Rad Laboratories (NYSE:BIO), Inc. (NYSE: BIO and BIO.B), known for its life science research and clinical diagnostics products, announced the appointment of Roop K. Lakkaraju as the company's new Executive Vice President and Chief Financial Officer, starting April 15, 2024.
Lakkaraju brings a wealth of financial expertise from his tenure at Benchmark Electronics (NYSE:BHE), where he has been serving as Executive Vice President and CFO since 2018. His background includes senior financial and operational roles at various multinational firms, including Support.com and Solectron.
Lakkaraju's career began in auditing with Grant Thornton and PricewaterhouseCoopers. He is a graduate of San Jose State University, holding a B.S. in Business Administration with a focus on Accounting.
Norman Schwartz, President and CEO of Bio-Rad, expressed confidence in Lakkaraju's ability to contribute to the company's financial and strategic goals. "Roop's extensive experience and track record in financial management, operations, mergers and acquisitions, and capital markets transactions will be instrumental in helping us shape and execute our financial strategy," Schwartz stated.
Lakkaraju himself commented on his new role, highlighting his commitment to driving Bio-Rad's financial and strategic initiatives to create long-term value for stakeholders.
Bio-Rad operates globally, with over 8,000 employees and reported revenues of $2.7 billion in 2023. The company's products are utilized by various institutions such as universities, research institutions, hospitals, and biopharmaceutical companies, contributing to advancements in science and healthcare.
This executive transition is based on a press release statement issued by Bio-Rad Laboratories, Inc.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.